Altasciences Leads Research on Chemical Nerve Agent Therapeutic from Preclinical to Clinical Phase I
LAVAL, Québec–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Altasciences?src=hash" target="_blank"gt;#Altascienceslt;/agt;–Altasciences announced today that they have been selected by Leidos Health to guide and support the…